Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Stepan (SCL) EBITDA (2016 - 2025)

Stepan (SCL) has disclosed EBITDA for 16 consecutive years, with -$55.5 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, EBITDA fell 820.82% year-over-year to -$55.5 million, compared with a TTM value of $12.6 million through Dec 2025, down 82.15%, and an annual FY2025 reading of $12.6 million, down 82.15% over the prior year.
  • EBITDA was -$55.5 million for Q4 2025 at Stepan, down from $21.8 million in the prior quarter.
  • Across five years, EBITDA topped out at $77.6 million in Q2 2022 and bottomed at -$156.0 million in Q4 2022.
  • Average EBITDA over 5 years is $15.2 million, with a median of $20.6 million recorded in 2023.
  • The sharpest move saw EBITDA plummeted 880.2% in 2022, then skyrocketed 115.96% in 2024.
  • Year by year, EBITDA stood at $20.0 million in 2021, then tumbled by 880.2% to -$156.0 million in 2022, then skyrocketed by 69.09% to -$48.2 million in 2023, then surged by 115.96% to $7.7 million in 2024, then crashed by 820.82% to -$55.5 million in 2025.
  • Business Quant data shows EBITDA for SCL at -$55.5 million in Q4 2025, $21.8 million in Q3 2025, and $18.0 million in Q2 2025.